Prazaxa



Indications and Reactions:

Role Indications Reactions
Primary
Atrial Fibrillation 45.2%
Hypertension 17.8%
Cerebrovascular Accident Prophylaxis 5.3%
Prophylaxis 3.9%
Thrombosis Prophylaxis 3.0%
Diabetes Mellitus 2.8%
Cardiac Failure 2.7%
Cardiac Failure Chronic 2.5%
Gastritis 2.0%
Insomnia 2.0%
Hyperlipidaemia 1.9%
Constipation 1.7%
Gastrooesophageal Reflux Disease 1.7%
Hyperuricaemia 1.6%
Arrhythmia 1.4%
Angina Pectoris 0.9%
Benign Prostatic Hyperplasia 0.9%
Chronic Obstructive Pulmonary Disease 0.9%
Cerebral Infarction 0.8%
Dementia 0.8%
Cerebral Infarction 24.8%
Embolic Stroke 8.3%
Renal Impairment 6.9%
Drug Ineffective 6.2%
Interstitial Lung Disease 6.2%
Wrong Technique In Drug Usage Process 6.2%
Shock Haemorrhagic 5.5%
Pulmonary Alveolar Haemorrhage 4.8%
Melaena 3.4%
Transient Ischaemic Attack 3.4%
Drug Effect Incomplete 2.8%
Lung Neoplasm Malignant 2.8%
Pneumonia 2.8%
Sepsis 2.8%
White Blood Cell Count Decreased 2.8%
Cardiac Failure Congestive 2.1%
Dizziness 2.1%
Eosinophilic Pneumonia 2.1%
Haemoptysis 2.1%
Haemorrhage 2.1%
Secondary
Atrial Fibrillation 39.6%
Prophylaxis 14.2%
Hypertension 9.0%
Cerebrovascular Accident Prophylaxis 8.0%
Thrombosis Prophylaxis 4.2%
Cardiac Failure 2.8%
Chronic Atrial Fibrillation 2.8%
Embolic Stroke 2.8%
Blood Pressure Decreased 1.9%
Chronic Bronchitis 1.9%
Neurogenic Bladder 1.9%
Prophylaxis Against Gastrointestinal Ulcer 1.9%
Gastritis 1.4%
Hyperlipidaemia 1.4%
Hyperuricaemia 1.4%
Anaemia 0.9%
Benign Prostatic Hyperplasia 0.9%
Cerebral Infarction 0.9%
Cerebrovascular Accident 0.9%
Constipation 0.9%
Cerebral Infarction 11.3%
Renal Impairment 7.5%
Sepsis 7.5%
Haematuria 5.7%
Haemoptysis 5.7%
Interstitial Lung Disease 5.7%
Melaena 5.7%
Radioisotope Scan Abnormal 5.7%
Wrong Technique In Drug Usage Process 5.7%
Asphyxia 3.8%
Diabetes Mellitus 3.8%
Fall 3.8%
Heat Illness 3.8%
Hypoxia 3.8%
Liver Disorder 3.8%
Lung Neoplasm Malignant 3.8%
Mediastinal Abscess 3.8%
Neoplasm Prostate 3.8%
Non-alcoholic Steatohepatitis 3.8%
Aplasia Pure Red Cell 1.9%
Concomitant
Product Used For Unknown Indication 24.7%
Rheumatoid Arthritis 14.2%
Atrial Fibrillation 9.6%
Prophylaxis 8.2%
Hypertension 6.4%
Cardiac Failure 5.9%
Constipation 2.7%
Cough 2.7%
Embolic Stroke 2.7%
Osteoporosis 2.7%
Prophylaxis Against Gastrointestinal Ulcer 2.7%
Thrombosis Prophylaxis 2.7%
Back Pain 1.8%
Benign Prostatic Hyperplasia 1.8%
Dementia Alzheimer's Type 1.8%
Diabetes Mellitus 1.8%
Dizziness 1.8%
Gastric Ulcer 1.8%
Gastritis 1.8%
Insomnia 1.8%
Cerebral Infarction 7.7%
Rash 7.7%
Restlessness 7.7%
Stomatitis 7.7%
Tuberculosis 7.7%
Tubulointerstitial Nephritis 7.7%
Atrial Fibrillation 3.8%
Cholecystitis Acute 3.8%
Death 3.8%
Drug-induced Liver Injury 3.8%
Haemoglobin Decreased 3.8%
Hepatitis Fulminant 3.8%
Hypokalaemia 3.8%
Lung Neoplasm Malignant 3.8%
Pneumonia 3.8%
Pneumonia Aspiration 3.8%
Prothrombin Time Prolonged 3.8%
Pyrexia 3.8%
Rash Generalised 3.8%
Renal Failure Acute 3.8%